Purpose and Overview:

Aerobiology in biodefense is crucial to the Nations goal of developing and licensing medical countermeasures to protect against aerosol biological threats. The FDA amended its new drug and biological product regulations to allow appropriate studies in animals to provide substantial evidence of the effectiveness of new drug and biological products used to reduce or prevent the effects of the biological agents. The regulatory approval for products that protect both the warfighter and the general population from aerosol attacks using biological agents depends on the quality of the infrastructure and the human expertise required to conduct these highly specialized efficacy studies. At present there are both very few laboratories equipped to conduct these studies and a limited number of people trained appropriately.

Aerobiology in Biodefense I, held 22-23 June 2005, brought together members of this burgeoning community (both those already working in the area and those who plan to in the near future) to discuss plans, data, form collaborations and discuss training opportunities.

Aerobiology in Biodefense II, will provide a formal venue for a continuation of this dialogue among members of the aerosol research community.

Session Topics:

• NIBC Partners Program Overview
• Facility Designs and Operations
• Aerosol Technology and Aerosol Characterization
• Overcoming Aerosol Challenges
• Countermeasure Development Perspectives
• Inhalation Animal Models

Dress Code:

Civilian Business Casual

Planning Committee:

Dr. Louise Pitt, USAMRIID
Dr. Judy Hewitt, NIAID
Dr. Jim Estep, BNBI
Dr. Charles Hobbs, LRRI

Program Chairperson:

M. Louise M. Pitt, Ph.D.
Director, Center for Aerobiological Sciences, USAMRIID
louise.pitt@us.army.mil

Program Assistant:

Tiffany Williams
Center for Aerobiological Sciences, USAMRIID
Tif.Smith@us.army.mil

Direct all Questions to- Conference Director:

Laurie Cobb
TRUE Research Foundation
210-829-1239
888-329-1239
Fax: 210-829-5513
conference@trueresearch.org